Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy

Teoh Jeremy Yuen Chun; Tsu James Hok Leung; Yuen Steffi Kar Kei; Chan Samson Yun Sang; Chiu Peter Ka Fung; Lee Wai-Man; Wong Ka-Wing; Ho Kwan-Lun; Hou Simon See Ming; Ng Chi-Fai; Yiu Ming-Kwong

首页> 外文期刊>Annals of surgical oncology >Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy

【24h】

Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy

机译：原发性雄激素剥夺治疗后前列腺癌骨转移患者的前列腺特异性抗原（PSA）最低点时间的预后意义及其与生存时间的关系

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study investigated the prognostic significance of time to the prostate-specific antigen nadir (TTPN) and its relationship to survival beyond TTPN in metastatic prostate cancer after primary androgen-deprivation therapy (ADT).

机译：这项研究调查了转移性前列腺癌中原发性雄激素剥夺治疗（ADT）后到达前列腺特异性抗原最低点（TTPN）的时间对预后的意义及其与TTPN以外生存率的关系。

著录项

来源
《Annals of surgical oncology》 |2015年第4期|共7页
作者
Teoh Jeremy Yuen Chun; Tsu James Hok Leung; Yuen Steffi Kar Kei; Chan Samson Yun Sang; Chiu Peter Ka Fung; Lee Wai-Man; Wong Ka-Wing; Ho Kwan-Lun; Hou Simon See Ming; Ng Chi-Fai; Yiu Ming-Kwong;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词

相似文献

外文文献
中文文献
专利

1. Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy [J] . Teoh Jeremy Yuen Chun, Tsu James Hok Leung, Yuen Steffi Kar Kei, Annals of surgical oncology . 2015,第4期

机译：原发性雄激素剥夺治疗后前列腺癌骨转移患者的前列腺特异性抗原（PSA）最低点时间的预后意义及其与生存时间的关系
2. Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP). [J] . Yasuhide Kitagawa, Satoru Ueno, Kouji Izumi, Journal of Cancer Research and Clinical Oncology . 2014,第4期

机译：在原发性雄激素剥夺治疗之后，Nadir前列腺特异性抗原（PSA）水平和时间至PSA Nadir作为日本大型前瞻性队列研究（J-Cap）的独立预后因素。
3. Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy. [J] . Huang SP, Bao BY, Wu MT, The Prostate . 2011,第11期

机译：前列腺特异性抗原（PSA）最低点和PSA最低点的时间对雄激素剥夺疗法治疗的前列腺癌疾病进展的影响。
4. Qualitative and quantitative investigation of glycans attached to Prostate-specific antigen (PSA) glycoprotein of healthy and cancer samples [C] . Ulrike Schweiger-Hufnagel, Kristina Marx, Wolfgang Jabs, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：对前列腺特异性抗原（PSA）糖蛋白对健康和癌症样品的定性和定量研究
5. Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy [D] . TAKEI, Akinori 2019

机译：雄激素剥夺治疗的持续时间和最低20 ng / dL的睾丸激素最低值可预测接受外照射的前列腺癌患者的睾丸激素恢复至超水平
6. The Importance of Time to Prostate-Specific Antigen (PSA) Nadir after Primary Androgen Deprivation Therapy in Hormone-Naïve Prostate Cancer Patients [O] . Takeshi Sasaki, Yoshiki Sugimura 2018

机译：激素初治前列腺癌患者初次雄激素剥夺治疗后对前列腺特异性抗原（PSA）最低点的时间的重要性
7. Association of time to prostate-specific antigen nadir and logarithm of prostate-specific antigen velocity after progression in metastatic prostate cancer with prior primary androgen deprivation therapy [O] . Jeremy YC Teoh, James HL Tsu, Steffi KK Yuen, 2017

机译：先前原发性雄激素剥夺治疗转移性前列腺癌进展后前列腺特异性抗原最低点的时间与前列腺特异性抗原速度的对数的关联

Prognostic Significance of Time to Prostate-Specific Antigen (PSA) Nadir and Its Relationship to Survival Beyond Time to PSA Nadir for Prostate Cancer Patients With Bone Metastases After Primary Androgen Deprivation Therapy

摘要

著录项

相似文献

相关主题

期刊订阅